General Trauma

Military Advances in Combat Trauma Care After a Decade of War and Translating Them to Civilian Practice

Activity Details
  • Credit Type: CME
  • Credit Amount: 1.00
  • Cost: $70.00
  • Release: Jul 24, 2014
  • Expires: Jul 23, 2020
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    ( Ratings)


Matthew J.  Martin Matthew J. Martin, MD
Associate Professor of Surgery
Division of Surgery
Uniformed Services University of Health Sciences
Tacoma, Washington

Trauma Medical Director
Madigan Army Medical Center
Tacoma, Washington

Carlos Rodriguez Carlos Rodriguez, DO, MBA
Director of Trauma and Surgical Critical Care
Walter Reed National Military Medical Center
Bethesda, Maryland

Needs Statement

Historically, major advances in the understanding and treatment of traumatic injuries have been gained from combat or wartime experiences. The past decade has witnessed the longest sustained period of combat by the United States military with the wars in Iraq and Afghanistan. This experience has resulted in multiple advances and improvement in the military medical system and forward combat care, with the highest reported battlefield survival rates in modern history. Many of the principles, practices, devices, and techniques that have come from this battlefield experience are highly relevant and applicable in the civilian trauma environment. There is a need for continued communication between military and civilian trauma providers in order to disseminate this information and foster continued dialog that will benefit both groups.

Target Audience

All physicians, nurses, and other medical staff personnel who provide care to severely injured trauma patients


Upon completion of this activity, participants will be able to:

  1. Describe at least 3 techniques being employed for hemorrhage control in the prehospital battlefield environment.
  2. Identify 4 potential advantages of damage control (or “1 to 1”) resuscitation over standard resuscitation.
  3. Discuss the 3 anatomic areas of injury that comprise the “Dismounted Complex Blast Injury”.
  4. Describe the optimal dose and timing strategy when using tranexamic acid (TXA) for severely injured patients.


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine, and Eastern Association for the Surgery of Trauma. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies

  • Patient care

Faculty Disclosure

No speaker, planner or content reviewer has any relevant financial relationships to disclose. The speaker will not discuss the off-label use of a product.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


This activity is jointly provided by the University of Kentucky and Eastern Association for the Surgery of Trauma.

Review Date

January 3, 2017

CE Content Concerns


Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504


  • The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
  • If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
  • Issues regarding activity content also will be reviewed and addressed by the Activity Director.
  • A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
  • Grievances will be considered when planning future activities.

Appeal Procedure

  • Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
  • The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
  • The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.